Ustekinumab: The Brand Name for This Psoriasis Treatment

What is the brand name for ustekinumab?
Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23.
Read more on en.wikipedia.org

Psoriasis, psoriatic arthritis, and Crohn’s disease are all conditions that are managed with the drug stekinumab. It is a human monoclonal antibody that suppresses inflammation by preventing the action of specific inflammatory proteins in the body. Ustekinumab is sold under the trade name Stelara, which is produced by Janssen Biotech, Inc. and was given the green light by the US Food and Drug Administration (FDA) in 2009.

The word “umab” frequently appears at the end of medication names. This is so because monoclonal antibodies, which are proteins created to target particular cells or proteins in the body, are referred to as “umab” suffixes. Because they may target particular cells and proteins without harming healthy cells, monoclonal antibodies are frequently utilized in medicine and are a viable therapy option for many disorders. Another class of medications with a unique naming scheme are ACE inhibitors. Angiotensin-converting enzyme inhibitors, sometimes known as ACE inhibitors, are a class of drugs used to treat heart failure, hypertension, and other cardiovascular disorders. Lisinopril (Prinivil, Zestril), enalapril (Vasotec), and ramipril (Altace) are a few examples of ACE inhibitors.

It can be useful to categorize drug suffixes into common kinds in order to remember them. As an illustration, monoclonal antibodies are denoted by the “umab” suffix, as was previously explained. The beta-blockers used to treat high blood pressure and other cardiac diseases have another common suffix, “-olol”. As was already mentioned, another suffix for ACE inhibitors is “-pril”.

In conclusion, the drug used to treat psoriasis, psoriatic arthritis, and Crohn’s disease is known by the brand name ustekinumab. It is a monoclonal antibody that functions by obstructing specific inflammatory proteins in the body. Depending on the type of prescription, drug names frequently follow particular naming standards, such as the “umab” suffix for monoclonal antibodies or the “-pril” suffix for ACE inhibitors. It may be simpler to recall various medicine types and purposes if you are aware of these naming practices.

Leave a Comment